Blueprint Medicines: Q1 Earnings Snapshot
By AP News
Published - May 04, 2023, 07:27 AM ET
Last Updated - Jun 21, 2023, 10:56 PM EDT
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Blueprint Medicines Corp. (BPMC) on Thursday reported a loss of $129.6 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of $2.15 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $2.66 per share.
The cancer drug developer posted revenue of $63.3 million in the period, also beating Street forecasts. Ten analysts surveyed by Zacks expected $42.7 million.
